Dr. Alan Kaye, MD

NPI: 1447292370
Total Payments
$273,058
2024 Payments
$652.14
Companies
28
Transactions
383
Medicare Patients
119
Medicare Billing
$9,990

Payment Breakdown by Category

Other$180,500 (66.1%)
Travel$52,415 (19.2%)
Consulting$28,099 (10.3%)
Food & Beverage$8,441 (3.1%)
Research$3,586 (1.3%)
Education$16.20 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $180,500 59 66.1%
Travel and Lodging $52,415 172 19.2%
Consulting Fee $28,099 10 10.3%
Food and Beverage $8,441 138 3.1%
Unspecified $3,586 2 1.3%
Education $16.20 2 0.0%

Payments by Type

General
$269,472
381 transactions
Research
$3,586
2 transactions

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme LLC $177,060 207 $0 (2024)
Depomed, Inc. $40,280 55 $0 (2017)
Assertio Therapeutics, Inc. $18,390 28 $0 (2018)
BioDelivery Sciences International, Inc. $11,090 8 $0 (2018)
Collegium Pharmaceutical, Inc. $8,800 1 $0 (2023)
EISAI INC. $4,275 1 $0 (2022)
Mallinckrodt LLC $2,750 7 $0 (2018)
Purdue Pharma L.P. $2,200 1 $0 (2023)
Par Pharmaceutical, Inc. $1,386 7 $0 (2018)
Sentynl Therapeutics, Inc. $1,386 7 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $652.14 13 Nevro Corp. ($183.45)
2023 $11,953 18 Collegium Pharmaceutical, Inc. ($8,800)
2022 $4,928 11 EISAI INC. ($4,275)
2021 $1,010 10 BOSTON SCIENTIFIC CORPORATION ($623.55)
2020 $5,175 10 Merck Sharp & Dohme Corporation ($5,046)
2019 $41,911 52 Merck Sharp & Dohme Corporation ($41,601)
2018 $112,677 148 Merck Sharp & Dohme Corporation ($76,222)
2017 $94,752 121 Merck Sharp & Dohme Corporation ($54,157)

All Payment Transactions

383 individual payment records from CMS Open Payments — Page 1 of 16

Date Company Product Nature Form Amount Type
10/14/2024 Nevro Corp. Senza (Device) Food and Beverage In-kind items and services $22.81 General
Category: Spinal Cord Stimulator
08/13/2024 Boston Scientific Corporation Food and Beverage In-kind items and services $57.30 General
Category: General - Pain Management_NMD
08/06/2024 Boston Scientific Corporation Food and Beverage In-kind items and services $26.32 General
Category: Clinical Trial Product_NMD
07/22/2024 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $124.99 General
Category: PAIN MANAGEMENT
07/01/2024 Boston Scientific Corporation Food and Beverage In-kind items and services $45.75 General
Category: General - Pain Management_NMD
06/11/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $22.66 General
Category: Diabetes Care
05/21/2024 Merck Sharp & Dohme LLC BRIDION (Drug) Food and Beverage In-kind items and services $17.70 General
Category: NEUROSCIENCE
04/05/2024 Nevro Corp. Senza (Device) Food and Beverage In-kind items and services $138.40 General
Category: Spinal Cord Stimulator
04/05/2024 Curonix LLC PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) Food and Beverage Cash or cash equivalent $97.95 General
Category: PAIN MANAGEMENT
03/07/2024 Saluda Medical Americas, Inc. Evoke (Device) Food and Beverage In-kind items and services $26.06 General
Category: Spinal Cord Stimulator
02/15/2024 Saluda Medical Americas, Inc. Evoke (Device) Food and Beverage In-kind items and services $30.10 General
Category: Spinal Cord Stimulator
02/08/2024 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $19.86 General
Category: PAIN MANAGEMENT
01/25/2024 Nevro Corp. Senza (Device) Food and Beverage In-kind items and services $22.24 General
Category: Spinal Cord Stimulator
11/30/2023 Boston Scientific Corporation Food and Beverage In-kind items and services $16.06 General
Category: General - Pain Management_NMD
11/16/2023 Saluda Medical Americas, Inc. Evoke SCS (Device) Food and Beverage In-kind items and services $136.64 General
Category: Spinal Cord Stimulation
10/31/2023 Boston Scientific Corporation Artisan (Device) Food and Beverage In-kind items and services $7.51 General
Category: Artisan_NMD
10/26/2023 Saluda Medical Americas, Inc. Evoke SCS (Device) Food and Beverage In-kind items and services $24.99 General
Category: Spinal Cord Stimulation
10/20/2023 Boston Scientific Corporation Food and Beverage In-kind items and services $12.86 General
Category: General - Pain Management_NMD
09/29/2023 Boston Scientific Corporation Food and Beverage In-kind items and services $38.38 General
Category: General - Pain Management_NMD
08/17/2023 Boston Scientific Corporation Food and Beverage In-kind items and services $151.14 General
Category: General - Pain Management_NMD
06/12/2023 Curonix LLC PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) Food and Beverage In-kind items and services $107.63 General
Category: PAIN MANAGEMENT
06/08/2023 Collegium Pharmaceutical, Inc. Xtampza (Drug), Belbuca, Nucynta Consulting Fee Cash or cash equivalent $8,800.00 General
Category: Opioid Analgesic
06/08/2023 Purdue Pharma L.P. Cash or cash equivalent $2,200.00 Research
Study: PMR 3033-11: Study 11
04/26/2023 Curonix LLC PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) Food and Beverage In-kind items and services $106.71 General
Category: PAIN MANAGEMENT
04/12/2023 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $14.72 General
Category: PAIN MANAGEMENT

Research Studies & Clinical Trials

Study Name Company Amount Records
PMR 3033-11: Study 11 Purdue Pharma L.P. $2,200 1
Transmucosal Immediate Release Fentanyl (TIRF) Risk Evaluation and Mitigation Strategy (REMS) program Teva Pharmaceuticals USA, Inc. $1,386 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 34 47 $7,365 $2,559
2022 4 67 88 $19,855 $5,778
2021 1 18 27 $3,240 $1,653
Total Patients
119
Total Services
162
Medicare Billing
$9,990
Procedure Codes
7

All Medicare Procedures & Services

7 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 17 23 $4,485 $1,660 37.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 17 24 $2,880 $898.55 31.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 19 29 $5,655 $2,024 35.8%
27096 Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance Facility 2022 13 18 $8,370 $1,515 18.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 22 28 $3,360 $1,376 41.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 13 13 $2,470 $863.28 35.0%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 18 27 $3,240 $1,653 51.0%

About Dr. Alan Kaye, MD

Dr. Alan Kaye, MD is a Anesthesiology healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447292370.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Kaye, MD has received a total of $273,058 in payments from pharmaceutical and medical device companies, with $652.14 received in 2024. These payments were reported across 383 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($180,500).

As a Medicare-enrolled provider, Kaye has provided services to 119 Medicare beneficiaries, totaling 162 services with total Medicare billing of $9,990. Data is available for 3 years (2021–2023), covering 7 distinct procedure/service records.

Practice Information

  • Specialty Anesthesiology
  • Other Specialties Pain Medicine
  • Location New Orleans, LA
  • Active Since 06/12/2006
  • Last Updated 12/21/2021
  • Taxonomy Code 207L00000X
  • Entity Type Individual
  • NPI Number 1447292370

Products in Payments

  • BRIDION (Drug) $177,160
  • Gralise (Drug) $58,617
  • BUNAVAIL 2.1 mg 30-count box (Drug) $11,090
  • Xtampza (Drug) $8,800
  • Dayvigo (Drug) $4,275
  • Abstral (Drug) $1,386
  • Fentora (Drug) $1,386
  • Superion (Device) $623.55
  • Senza (Device) $371.47
  • PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $312.29
  • OFIRMEV (Drug) $264.88
  • Superion Indirect Decompression System (Device) $251.93
  • QUTENZA (Drug) $218.52
  • Proclaim Family of SCS IPGs (Device) $210.48
  • Evoke SCS (Device) $161.63
  • mild Device Kit (Device) $150.29
  • Omnia (Device) $149.34
  • PROCLAIM (Device) $142.69
  • ANJESO (Drug) $127.29
  • PNB AND ACCESSORIES (Device) $123.81

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anesthesiology Doctors in New Orleans